We highlight the profound difference early intervention makes in the trajectory of psychotic disorders, reducing symptom severity, suicide risk, and functional impairment.

A dextromethorphan-bupropion combo tablet shows promise in treating major depression. The FDA recognized its potential in 2019, so stay tuned for more updates on this novel treatment.

Few medications are as complex to use as clozapine. This guide will equip you with the necessary knowledge and insights to prescribe it, monitor for side effects, and recognize key risks.

We examine effective suicide prevention techniques, highlighting simple yet impactful methods such as post-hospitalization follow-ups via phone calls or postcards. Dr. Mann offers insight into these and other interventions that have been successful in lowering suicide rates.

Here we focus on the safe administration of lithium, discussing how to manage both common and lesser- known side effects so that you can ensure a comprehensive approach to your patients’ care.

A study on gender-affirming hormones in adolescents and adults found they are linked to better mental health in transgender people, leading to reduced psychological distress and suicidal thoughts. The findings reinforce the Endocrine Society's advice to provide transgender adolescents with access to GAH.

By successfully completing the test you will be awarded a certificate for 2 CME credit.

A survey of gun ownership and gun purchasing plans found that individuals with depressive symptoms were significantly more likely to purchase a gun, or plan to purchase a gun, compared to non-depressed individuals, especially during the COVID-19 pandemic.